Fennell, Dean A <br/><br/>
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  04 2019 
 - 790-798 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2018.79.0543  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Benzamides--adverse effects<br/>Diarrhea--chemically induced<br/>Double-Blind Method<br/>Fatigue--chemically induced<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mesothelioma--drug therapy<br/>Mesothelioma, Malignant<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neurofibromin 2--metabolism<br/>Pleural Neoplasms--drug therapy<br/>Pyrazines--adverse effects<br/>Sulfonamides--adverse effects<br/>Treatment Outcome